References
- AzzizRWoodsKSReynaRKeyTJKnochenhauerESYildizBOThe prevalence and features of the polycystic ovary syndrome in an unselected populationJ Clin Endocrinol Metab20048962745274915181052
- KauffmanRPBakerTEBakerVMDiMarinoPCastracaneDEndocrine and metabolic differences among phenotypic expressions of polycystic ovary syndrome according to the 2003 Rotterdam consensus criteriaAm J Obstet Gynecol20081986670.e1670.e1018355776
- Diamanti-KandarakisEKouliCRBergieleATA survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profileJ Clin Endocrinol Metab199984114006401110566641
- AsuncionMCalvoRMSan MillanJLSanchoJAvilaSEscobar-MorrealeHFA prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from SpainJ Clin Endocrinol Metab20008572434243810902790
- MarchWAMooreVMWillsonKJPhillipsDINormanRJDaviesMJThe prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteriaHum Reprod201025254455119910321
- SteinIFLeventhalMIAmenorrhea associated with bilateral polycystic ovariesAm J Obstet Gynecol193529181191
- ZawadskiJKDunaifADiagnostic criteria for polycystic ovary syndrome; toward a rational approachDunaifAGivensJRHaseltineFPPolycystic Ovary SyndromeBoston MABlackwell Scientific1992377384
- Rotterdam ESHRE/ASRM–Sponsored PCOS Consensus Workshop GroupRevised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)Hum Reprod2004191414714688154
- GoverdeAJvan KoertAJEijkemansMJIndicators for metabolic disturbances in anovulatory women with polycystic ovary syndrome diagnosed according to the Rotterdam consensus criteriaHum Reprod200924371071719095675
- MoranLJMissoMLWildRANormanRJImpaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysisHum Reprod Update201016434736320159883
- YildizBOBozdagGYapiciZEsinlerIYaraliHPrevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteriaHum Reprod201227103067307322777527
- AzzizRCarminaEDewaillyDPositions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guidelineJ Clin Endocrinol Metab200691114237424516940456
- FauserBCTarlatzisBCRebarRWConsensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop GroupFertil Steril2012971283822153789
- National Institutes of Health (NIH)Evidence-based Methodology Workshop on Polycystic Ovary Syndrome123–52012 Available from: https://prevention.nih.gov/docs/programs/pcos/finelreport.pdf
- ConwayGDewaillyDDiamanti-KandarakisEThe polycystic ovary syndrome: a position statement from the European Society of EndocrinologyEur J Endocrinol2014171412924743401
- LegroRSArslanianSAEhrmannDADiagnosis and treatment of polycystic ovary syndrome: an endocrine society clinical practice guidelineJ Clin Endocrinol Metab201398124565459224151290
- OrioFPalombaSReproductive endocrinology: new guidelines for the diagnosis and treatment of PCOSNat Rev Endocrinol201410313013224322653
- WeltCKCarminaEClinical review: lifecycle of polycystic ovary syndrome (PCOS): from in utero to menopauseJ Clin Endocrinol Metab201398124629463824064685
- HullMGEpidemiology of infertility and polycystic ovarian disease: endocrinological and demographic studiesGynecol Endocrinol198712352453140583
- BalenAHConwayGSKaltsasGPolycystic ovary syndrome: the spectrum of the disorder in 1741 patientsHum Reprod199510210721118567849
- TianLShenHLuQNormanRJWangJInsulin resistance increases the risk of spontaneous abortion after assisted reproduction technology treatmentJ Clin Endocrinol Metab20079241430143317244790
- JungheimESLanzendorfSEOdemRRMoleyKHChangASRattsVSMorbid obesity is associated with lower clinical pregnancy rates after in vitro fertilization in women with polycystic ovary syndromeFertil Steril200992125626118692801
- JakubowiczDJEssahPASeppäläMReduced serum glycodelin and insulin-like growth factor-binding protein-1 in women with polycystic ovary syndrome during first trimester of pregnancyJ Clin Endocrinol Metab200489283383914764802
- PalombaSRussoTOrioFJrUterine effects of clomiphene citrate in women with polycystic ovary syndrome: a prospective controlled studyHum Reprod200621112823282916835214
- PalombaSOrioFJrFalboARussoTTolinoAZulloFEffects of metformin and clomiphene citrate on ovarian vascularity in patients with polycystic ovary syndromeFertil Steril20068661694170117074337
- TeissierMPChableHPaulhacSAubardYComparison of follicle steroidogenesis from normal and polycystic ovaries in women undergoing IVF: relationship between steroid concentrations, follicle size, oocyte quality and fecundabilityHum Reprod200015122471247711098013
- PalombaSFalboARussoTOrioFTolinoAZulloFSystemic and local effects of metformin administration in patients with polycystic ovary syndrome (PCOS): relationship to the ovulatory responseHum Reprod20102541005101320106839
- WoodJRDumesicDAAbbottDHStraussJF3rdMolecular abnormalities in oocytes from women with polycystic ovary syndrome revealed by microarray analysisJ Clin Endocrinol Metab200792270571317148555
- DahlgrenEJohanssonSLindstedtGWomen with polycystic ovary syndrome wedge resected in 1956 to 1965: a long-term follow-up focusing on natural history and circulating hormonesFertil Steril19925735055131740195
- CibulaDCifkovaRFantaMPoledneRZivnyJSkibovaJIncreased risk of non-insulin dependent diabetes mellitus, arterial hypertension and coronary artery disease in perimenopausal women with a history of the polycystic ovary syndromeHum Reprod20001578578910739820
- WildSPierpointTMcKeiguePJacobsHCardiovascular disease in women with polycystic ovary syndrome at long-term follow-up: a retrospective cohort studyClin Endocrinol (Oxf)20005259560010792339
- HudecovaMHolteJOlovssonMSundström PoromaaILong-term follow-up of patients with polycystic ovary syndrome: reproductive outcome and ovarian reserveHum Reprod20092451176118319168874
- KorhonenSHippelainenMVanhalaMHeinonenSNiskanenLThe androgenic sex hormone profile is an essential feature of metabolic syndrome in premenopausal women: a controlled community-based studyFertil Steril2003791327133412798879
- EltingMWKorsenTJRekers-MombargLTSchoemakerJWomen with polycystic ovary syndrome gain regular menstrual cycles when ageingHum Reprod200015242810611183
- KalraSKRatcliffebSJDokrasnAIs the fertile windows extended in women with polycystic ovary syndrome? Utilizing the Society for Assisted Reproductive Technology registry to assess the impact of reproductive aging on live-birth rateFertil Steril2013100120821323557762
- HeijnenEMEijkemansMJHughesEGLavenJSMacklonNSFauserBCA meta-analysis of outcomes of conventional IVF in women with polycystic ovary syndromeHum Reprod Update2006121132116123051
- Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop GroupRevised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndromeFertil Steril20048111925
- PalombaSde WildeMAFalboAKosterMPHLa SalaGBFauserCJMPregnancy complications in women with polycystic ovary syndrome: new clinical and pathophysiological insightsHum Reprod Update2015627dmv02926117684
- BoomsmaCMEijkemansMJHughesEGVisserGHFauserBCMacklonNSA meta-analysis of pregnancy outcomes in women with polycystic ovary syndromeHum Reprod Update200612667368316891296
- KjerulffLESanchez-RamosLDuffyDPregnancy outcomes in women with polycystic ovary syndrome: a metaanalysisAm J Obstet Gynecol20112046558e1558.e621752757
- QinJZPangLHLiMJFanXJHuangRDChenHYObstetric complications in women with polycystic ovary syndrome: a systematic review and meta-analysisReprod Biol Endocrinol2013261156
- LiuLTongXJiangLLiTCZhouFZhangSA comparison of the miscarriage rate between women with and without polycystic ovarian syndrome undergoing IVF treatmentEur J Obstet Gynecol Reprod Biol2014176417818224680396
- PalombaSChiossiGFalboALow-grade chronic inflammation in pregnant women with polycystic ovary syndromeJ Clin Endocrinol Metab20149982942295124873996
- PalombaSFalboAChiossiGLipid profile in pregnant women with polycystic ovary syndromeSteroids201488364324945113
- de WildeMAVeltman-VerhulstSMGoverdeAJPreconception predictors of gestational diabetes: a multicentre prospective cohort study on the predominant complication of pregnancy in polycystic ovary syndromeHum Reprod20142961327123624777850
- NaverKVGrinstedJLarsenSOIncreased risk of preterm delivery and pre-eclampsia in women with polycystic ovary syndrome and hyperandrogenaemiaBJOG2014121557558124418062
- HanARKimHOChaSWAdverse pregnancy outcomes with assisted reproductive technology in non-obese women with polycystic ovary syndrome: a case-control studyClin Exp Reprod Med201138210310822384427
- RoosNKielerHSahlinLEkman-OrdebergGFalconerHStephanssonORisk of adverse pregnancy outcomes in women with polycystic ovary syndrome: population based cohort studyBMJ2011343d630921998337
- WildRACarminaEDiamanti-KandarakisEAssessment of cardiovascular risk and prevention of cardiovascular disease in women with the Polycystic Ovary Syndrome: a consensus statement by the Androgen Wxcess and Polycystic Ovary Syndrome (AE-PCOS) SocietyJ Clin Endocrinol Metab20109522038204920375205
- ToulisKAGoulisDGMintzioriGMeta-analysis of cardiovascular disease risk markers in women with polycystic ovary syndromeHum Reprod Update201117674176021628302
- YusufSHawkenSOunpuuSEffect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control studyLancet2004364943893795215364185
- Martins WdePSoaresGMVieiraCSdos ReisRMde SáMFFerrianiRACardiovascular risk markers in polycystic ovary syndrome in women with and without insulin resistanceRev Bras Ginecol Obstet200931311111619547885
- ScicchitanoPDentamaroICarbonaraRCardiovascular risk in women with PCOSInt J Endocrinol Metab201210461161823843832
- ChenMJYangWSYangJHChenCLHoHNYangYSRelationship between androgen levels and blood pressure in young women with polycystic ovary syndromeHypertension20074961442144717389259
- HolteJGennarelliGBerneCBerghTLithellHElevated ambulatory day-time blood pressure in women with polycystic ovary syndrome: a sign of a pre-hypertensive state?Hum Reprod199611123288671152
- LegroRSKunselmanARDunaifAPrevalence and predictors of dyslipidemia in women with polycystic ovary syndromeAm J Med2001111860761311755503
- EssahPANestlerJECarminaEDifferences in dyslipidemia between American and Italian women with polycystic ovary syndromeJ Endocrinol Invest2008311354118296903
- AustinMAKingMCVranizanKMKraussRMAtherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease riskCirculation19908224955062372896
- RizzoMBerneisKLipid triad or atherogenic lipoprotein phenotype: a role in cardiovascular prevention?J Atheroscler Thromb200512523723916205019
- BrunzellJDAyyobiAFDyslipidemia in the metabolic syndrome and type 2 diabetes mellitusAm J Med200311524S28S14678862
- ValkenburgOSteegers-TheunissenRPSmedtsHPA more atherogenic serum lipoprotein profile is present in women with polycystic ovary syndrome: a case-control studyJ Clin Endocrinol Metab200893247047618056772
- ZhangJFanPLiuHBaiHWangYZhangFApolipoprotein A-I and B levels, dyslipidemia and metabolic syndrome in south-west Chinese women with PCOSHum Reprod20122782484249322674204
- JoharatnamJBarberTMWebberLConwayGSMcCarthyMIFranksSDeterminants of dyslipidaemia in probands with polycystic ovary syndrome and their sistersClin Endocrinol (Oxford)2011746714719
- LegroRSGnatukCLKunselmanARDunaifAChanges in glucose tolerance over time in women with polycystic ovary syndrome: a controlled studyJ Clin Endocrinol Metab20059063236324215797965
- NormanRJMastersLMilnerCRWangJXDaviesMJRelative risk of conversion from normoglycaemia to impaired glucose tolerance or non-insulin dependent diabetes mellitus in polycystic ovarian syndromeHum Reprod20011691995199811527911
- WangETCalderon-MargalitRCedarsMIPolycystic ovary syndrome and risk for long-term diabetes and dyslipidemiaObstet Gynecol2011117161321173640
- PuglieseDNicolettiGAndreulaCCicconeMTriggianiGCombined protein C deficiency and protein C activated resistance as a cause of caval, peripheral, and cerebral venous thrombosis – a case reportAngiology19984953994019591532
- RidkerPMClinical application of C-reactive protein for cardiovascular disease detection and preventionCirculation2003107336336912551853
- OhJYLeeJALeeHOhJYSungYAChungHSerum C-reactive protein levels in normal-weight polycystic ovary syndromeKorean J Intern Med200924435035519949734
- MöhligMSprangerJOsterhoffMThe polycystic ovary syndrome per se is not associated with increased chronic inflammationEur J Endocrinol2004150452553215080783
- YaraliHYildirirAAybarFDiastolic dysfunction and increased serum homocysteine concentrations may contribute to increased cardiovascular risk in patients with polycystic ovary syndromeFertil Steril200176351151611532474
- SchachterMRazielAFriedlerSStrassburgerDBernORon-ElRInsulin resistance in patients with polycystic ovary syndrome is associated with elevated plasma homocysteineHum Reprod200318472172712660262
- LoverroGLorussoFMeiLDepaloRCormioGSelvaggiLThe plasma homocysteine levels are increased in polycystic ovary syndromeGynecol Obstet Invest200253315716212053100
- WiltgenDSpritzerPMVariation in metabolic and cardiovascular risk in women with different polycystic ovary syndrome phenotypesFertil Steril20109462493249620338557
- SamyNHashimMSayedMSaidMClinical significance of inflammatory markers in polycystic ovary syndrome: their relationship to insulin resistance and body mass indexDis Markers200926416317019729797
- EltingMWKorsenTJSchoemakerJObesity, rather than menstrual cycle pattern or follicle cohort size, determines hyperinsulinaemia, dyslipidaemia and hypertension in ageing women with polycystic ovary syndromeClin Endocrinol (Oxf)200155676777611895219
- WildSPierpointTJacobsHMcKeiguePLong-term consequences of polycystic ovary syndrome: results of a 31 year follow-up studyHum Fertil (Camb)20003210110511844363
- WildRAGrubbBHartzAVan NortJJBachmanWBartholomewMClinical signs of androgen excess as risk factors for coronary artery diseaseFertil Steril19905422552592143147
- BirdsallMAFarquharCMWhiteHDAssociation between polycystic ovaries and extent of coronary artery disease in women having cardiac catheterizationAnn Intern Med1997126132358992921
- DokrasACardiovascular disease risk in women with PCOSSteroids201378877377623624351
- SprungVSAtkinsonGCuthbertsonDJEndothelial function measured using flow-mediated dilation in polycystic ovary syndrome: a meta-analysis of the observational studiesClin Endocrinol (Oxf)201378343844622775449
- ParadisiGSteinbergHOHempflingAPolycystic ovary syndrome is associated with endothelial dysfunctionCirculation2001103101410141511245645
- KravaritiMNakaKKKalantaridouSNPredictors of endothelial dysfunction in young women with polycystic ovary syndromeJ Clin Endocrinol Metab20059095088509515985492
- MeyerMLMalekAMWildRAKorytkowskiMTTalbottEOCarotid artery intima-media thickness in polycystic ovary syndrome: a systematic review and meta-analysisHum Reprod Update201218211212622108382
- AradYSpadaroLAGoodmanKNewsteinDGuerciADPrediction of coronary events with electron beam computed tomographyJ Am Coll Cardiol20003641253126011028480
- ChristianRCDumesicDABehrenbeckTObergALSheedyPFFitzpatrickLAPrevalence and predictors of coronary artery calcification in women with polycystic ovary syndromeJ Clin Endocrinol Metab20038862562256812788855
- TalbottEOGuzickDSSutton-TyrrellKHugh-PemuKPZborowskiJVRemsbergKEEvidence for association between polycystic ovary syndrome and premature carotid atherosclerosis in middle-aged womenArterioscler Thromb Vasc Biol200020112414242111073846
- Luque-RamirezMMendieta-AzconaCAlvarez-BlascoFEscobar-MorrealeHFAndrogen excess is associated with the increased carotid intima-media thickness observed in young women with polycystic ovary syndromeHum Reprod200722123197320317933750
- TalbottEOZborowskiJRagerJStragandJRIs there an independent effect of polycystic ovary syndrome (PCOS) and menopause on the prevalence of subclinical atherosclerosis in middle aged women?Vasc Health Risk Manag20084245346218561521
- SchmidtJLandin-WilhelmsenKBrännströmMDahlgrenECardiovascular disease and risk factors in PCOS women of postmenopausal age: a 21-year controlled follow-up studyJ Clin Endocrinol Metab201196123794380321956415
- De GrootPCDekkersOMRomijnJADiebenSWHelmerhorstFMPCOS, coronary heart disease, stroke and the influence of obesity: a systematic review and meta-analysisHum Reprod Update201117449550021335359
- AndersonSABarryJAHardimanPJRisk of coronary heart disease and risk of stroke in women with polycystic ovary syndrome: a systematic review and meta-analysisInt J Cardiol2014176248648725096551
- LimSSDaviesMJNormanRJMoranLJOverweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysisHum Reprod Update201218661863722767467
- ChingHLBurkeVStuckeyBGQuality of life and psychological morbidity in women with polycystic ovary syndrome: body mass index, age and the provision of patient information are significant modifiersClin Endocrinol (Oxf)200766337337917302871
- GlueckCJDharashivkarSWangPObesity and extreme obesity, manifest by ages 20–24 years, continuing through 32–41 years in women, should alert physicians to the diagnostic likelihood of polycystic ovary syndrome as a reversible underlying endocrinopathyEur J Obstet Gynecol Reprod Biol2005122220621216219521
- ChenXNiRMoYLiLYangDAppropriate BMI levels for PCOS patients in Southern ChinaHum Reprod20102551295130220172872
- SteptoNKCassarSJohamAEWomen with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic-hyperinsulaemic clampHum Reprod201328377778423315061
- TeedeHJJohamAEPaulELongitudinal weight gain in women identified with polycystic ovary syndrome: results of an observational study in young womenObesity20132181526153223818329
- BatesGWLegroRSLong-term management of Polycystic Ovarian Syndrome (PCOS)Mol Cel Endocrinol20133731–29197
- CarminaEBucchieriSEspositoAAbdominal fat quantity and distribution in women with polycystic ovary syndrome and extent of its relation to insulin resistanceJ Clin Endocrinol Metab20079272500250517405838
- CascellaTPalombaSDe SioIVisceral fat is associated with cardiovascular risk in women with polycystic ovary syndromeHum Reprod200823115315918024952
- LordJThomasRFoxBAcharyaUWilkinTThe central issue? Visceral fat mass is a good marker of insulin resistance and metabolic disturbance in women with polycystic ovary syndromeBJOG2006113101203120916753044
- PasqualiRCasimirriFVenturoliSBody fat distribution has weight-independent effects on clinical, hormonal, and metabolic features of women with polycystic ovary syndromeMetabolism19944367067138201958
- VrbikovaJHainerVObesity and polycystic ovary syndromeObes Facts200921263520054201
- SamSDunaifAPolycystic ovary syndrome: syndrome XX? TrendsEndocrinol Metab2003148365370
- Diamanti-KandarakisEDunaifAInsulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implicationsEndocr Rev2012336981103023065822
- TosiFDi SarraDKaufmanJMTotal body fat and central fat mass independently predict insulin resistance but not hyperandrogenemia in women with polycystic ovary syndromeJ Clin Endocrinol Metab2015100266166925393642
- AlbertiKGZimmetPShawJInternational Diabetes Federation: a consensus on type 2 diabetes preventionDiabet Med200724545146317470191
- GambineriAPattonLAltieriPPolycystic ovary syndrome is a risk factor for type 2 diabetes: results from a long-term prospective studyDiabetes20126192369237422698921
- DaanNMLouwersYVKosterMPCardiovascular and metabolic profiles amongst different polycystic ovary syndrome phenotypes: who is really at risk?Fertil Steril201410251444145125239303
- ApridonidzeTEssahPAIuornoMJNestlerJEPrevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndromeJ Clin Endocrinol Metab20059041929193515623819
- JovanovicVPCarminaELoboRANot all women diagnosed with PCOS share the same cardiovascular risk profilesFertil Steril201094382683219501355
- MoranLTeedeHMetabolic features of the reproductive phenotypes of polycystic ovary syndromeHum Reprod Update200915447748819279045
- MoranLJNormanRJTeedeHJMetabolic risk in PCOS: phenotype and adiposity impactTrends Endocrinol Metab201526313614325591984
- MoranLJStraussBJTeedeHJDiabetes risk score in the diagnostic categories of polycystic ovary syndromeFertil Steril20119551742174821316662
- HardimanPPillayOCAtiomoWPolycystic ovary syndrome and endometrial carcinomaLancet200336193711810181212781553
- GenazzaniARGadducciAGambaccianiMControversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert WorkshopClimacteric20014318119311588941
- BarryJAAziziaMMHardimanPJRisk of endometrial, ovarian and breast cancer in women with polycystic ovary syndrome: a systematic review and meta-analysisHum Reprod Update201420574875824688118
- BroekmansFJKnauffEAHValkenburgOLavenJSEijkemansMJFauserBCJMPCOS according to the Rotterdam consensus criteria: change in prevalence among WHO-II anovulation and association with metabolic factorsBJOG2006113101210121716972863
- HaoulaZSalmanMAtiomoWEvaluating the association between endometrial cancer and polycystic ovary syndromeHum Reprod20122751327133122367984
- ChittendenBGFullertonGMaheshwariABhattacharyaSPolycystic ovary syndrome and the risk of gynaecological cancer: a systematic reviewReprod Biomed Online200919339840519778486
- GiovannucciEMetabolic syndrome, hyperinsulinemia, and colon cancer: a reviewAm J Clin Nutr2007863s836s84218265477
- IatrakisGZervoudisSSaviolakisAWomen younger than 50 years with endometrial cancerEur J Gynaecol Oncol200627439940017009635
- ZucchettoASerrainoDPoleselJHormone-related factors and gynecological conditions in relation to endometrial cancer riskEur J Cancer Prev200918431632119554665
- NiwaKImaiAHashimotoMA case-control study of uterine endometrial cancer of pre- and post-menopausal womenOncol Rep200071899310601598
- DowlingRJGoodwinPJStambolicVUnderstanding the benefit of metformin use in cancer treatmentMBC Med2011933
- EngelmanJACantleyLCChemoprevention meets glucose controlCancer Prev Res20109910491052
- WangYLXieYYuLMetformin promotes progesterone receptor expression via inhibition of mammalian target of rapamycin (mTOR) in endometrial cancer cellsJ Steroid Biochem Mol Biol20111263–511312021168492
- LegroRSZainoRJDemersLMThe effects of metformin and rosiglitazone, alone and in combination, on the ovary and endometrium in polycystic ovary syndromeAm J Obstet Gynecol2007196440217403436
- ShafieeMNKhanGAriffinRPreventing endometrial cancer risk in polycystic ovarian syndrome (PCOS) women: could metformin help?Gynecol Oncol2014132124825324183733
- PierpointTMcKeiguePMIsaacsAJWildSHJacobsHSMortality of women with polycystic ovary syndrome at long-term follow-upJ Clin Epidemiol19985175815869674665
- DokrasACliftonSFutterweitWWildRIncreased risk for abnormal depression scores in women with polycystic ovary syndrome: a systematic review and meta-analysisObstet Gynecol2011117114515221173657
- CoffeySBanoGMasonHHealth-related quality of life in women with PCOS: a comparison with the general population using the PCOS questionnaire and the SF-36Gynecol Endocrinol2006222808616603432
- BarnardLFerridayDGuentherNStraussBBalenAHDyeLQuality of life and psychological wellbeing in polycystic ovary syndromeHum Reprod20072282279228617537782
- MoranLJDeeksAAGibson-HelmMETeedeHJPsychological parameters in the reproductive phenotypes of polycystic ovary syndromeHum Reprod20122772082208822493025
- DokrasACliftonSFutterweitWWildRIncreased prevalence of anxiety symptoms in women with polycystic ovary syndrome: systematic review and meta-analysisFertil Steril201297122523022127370
- LaggariVDiaremeSChristogiorgosSAnxiety and depression in adolescents with polycystic ovary syndrome and Mayer-Rokitansky-Kuster-Hauser syndromeJ Psychosom Obstet Gynaecol2009302838819533486
- JonesGBenesKClarkTThe PCOS health-related quality of life questionnaire (PCSOQ): a validationHum Reprod200419237137714747184
- BarryJAKuczmierczykARHardimanPJAnxiety and depression in polycystic ovary syndrome: a systematic review and meta-analysisHum Reprod20112692442245121725075
- Harris-GlockerMDavidsonKKochmanLGuzickDHoegerKImprovement in quality-of-life questionnaire measures in obese adolescent females with polycystic ovary syndrome treated with lifestyle changes and oral contraceptives, with or without metforminFertil Steril20109331016101919781696
- ThomsonRLBuckleyJDLimSSLifestyle management improves quality of life and depression in overweight and obese women with polycystic ovary syndromeFertil Steril20109451812181620004371
- JedelEGustafsonDWaernMSex steroids, insulin sensitivity and sympathetic nerve activity in relation to affective symptoms in women with polycystic ovary syndromePsychoneuroendocrinology201136101470147921549510
- WeinerCLPrimeauMEhrmannDAAndrogens and mood dysfunction in women: comparison of women with PCOS to healthy controlsPsychosom Med200466335636215184695
- ManssonMHolteJLandin-WilhelmsenKDahlgrenEJohanssonALandenMWomen with polycystic ovary syndrome are often depressed or anxious – a case control studyPsychoneuroendocrinology20083381132113818672334
- OrioFTafuriDAscioneALifestyle changes in the management of adulthood and childhood obesityMinerva Endocrinol2014
- PalombaSGiallauriaFFalboAStructured exercise training programme versus hypocaloric hyperproteic diet in obese polycystic ovary syndrome patients with anovulatory infertility: a 24-week pilot studyHum Reprod200823364265018158291
- PalombaSFalboAGiallauriaFSix weeks of structured exercise training and hypocaloric diet increases the probability of ovulation after clomiphene citrate in overweight and obese patients with polycystic ovary syndrome: a randomized controlled trialHum Reprod201025112783279120858697
- BrownJFarquharCBeckJBoothroydCHughesEClomiphene and anti-oestrogens for ovulation induction in PCOS [review]Cochrane Database Syst Rev200974CD00224919821295
- PalombaSFalboAZulloFManagement strategies for ovulation induction in women with polycystic ovary syndrome and known clomifene citrate resistanceCurr Opin Obstet Gynecol200921646547319809318
- PalombaSAromatase inhibitors for ovulation inductionJ Clin Endocrinol Metab201510051742174725710566
- FranikSKremerJANelenWLFarquharCAromatase inhibitors for subfertile women with polycystic ovary syndromeCochrane Database Syst Rev201421CD01028724563180
- LegroRSZhangHEunice Kennedy Shriver NICHD Reproductive Medicine NetworkLetrozole or clomiphene for infertility in the polycystic ovary syndromeN Engl J Med2014371151463146425295506
- VitekWAlurSHoegerKMOff-label drug use in the treatment of polycystic ovary syndromeFertil Steril2015103360561125726702
- PalombaSFalboAZulloFOrioFJrEvidence-based and potential benefits of metformin in the polycystic ovary syndrome: a comprehensive reviewEndocr Rev200930115019056992
- CassinaMDonàMDi GianantonioELittaPClementiMFirst-trimester exposure to metformin and risk of birth defects: a systematic review and meta-analysisHum Reprod Update201420565666924861556
- PalombaSFalboALa SalaGBEffects of metformin in women with polycystic ovary syndrome treated with gonadotrophins for in vitro fertilisation and intracytoplasmic sperm injection cycles: a systematic review and meta-analysis of randomised controlled trialsBJOG2013120326727623194199
- MitraSNayakPKAgrawalSLaparoscopic ovarian drilling: an alternative but not the ultimate in the management of polycystic ovary syndromeJ Nat Sci Biol Med201561404825810633
- BayramNvan WelyMvan Der VeenFRecombinant FSH versus urinary gonadotrophins or recombinant FSH for ovulation induction in subfertility associated with polycystic ovary syndromeCochrane Database Syst Rev200112CD00212111406034
- Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop GroupConsensus on infertility treatment related to polycystic ovary syndromeHum Reprod200823346247718308833
- BelosiCSelvaggiLApaRIs the PCOS diagnosis solved by ESHRE/ASRM 2003 consensus or could it include ultrasound examination of the ovarian stroma?Hum Reprod200621123108311517053004
- AbbottDHTarantalAFDumesicDAFetal, infant, adolescent and adult phenotypes of polycystic ovary syndrome in prenatally androgenized female rhesus monkeysAm J Perinatol2009719776784
- EhrmannDAPolycystic ovary syndromeN Engl J Med2005352121223123615788499
- HurdWWAbdel-RahmanMYIsmailSAAbdellahMASchmotzerCLSoodAComparison of diabetes mellitus and insulin resistance screening methods for women with polycystic ovary syndromeFertil Steril20119641043104721813121
- LerchbaumESchwetzVGiulianiAObermayer-PietschBAssessment of glucose metabolism in polycystic ovary syndrome: HbA1c or fasting glucose compared with the oral glucose tolerance test as a screening methodHum Reprod20132892537254423756702
- Velling MagnussenLMummHAndersenMGlintborgDHemoglobin A1c as a tool for the diagnosis of type 2 diabetes in 208 premenopausal women with polycystic ovary syndromeFertil Steril20119651275128021982282
- BrohallGSchmidtCBehreCJHultheJWikstrandJFagerbergBAssociation between impaired glucose tolerance and carotid atherosclerosis: a study in 64-year-old women and a meta-analysisNutr Metab Cardiovasc Dis200919532733319097767
- RosenzweigJLFerranniniEGrundySMPrimary prevention of cardiovascular disease and type 2 diabetes in patients at metabolic risk: an endocrine society clinical practice guidelineJ Clin Endocrinol Metab200893103671368918664543
- MoscaLGuidelines for prevention of cardiovascular disease in women: a summary of recommendationsPrev Cardiol200710Suppl 4192517917527
- TimmermansAOpmeerBCKhanKSEndometrial thickness measurement for detecting endometrial cancer in women with postmenopausal bleeding: a systematic review and meta-analysisObstet Gynecol2010116116016720567183
- KossLGSchreiberKOberlanderSGMoussourisHFLesserMDetection of endometrial carcinoma and hyperplasia in asymptomatic womenObstet Gynecol19846411116738931
- SmithRAvon EschenbachACWenderRACS Prostate Cancer Advisory CommitteeACS Colorectal Cancer Advisory CommitteeACS Endometrial Cancer Advisory CommitteeAmerican Cancer Society guidelines for the early detection of cancer: update of early detection guidelines for prostate, colorectal, and endometrial cancers. Also: update 2001–testing for early lung cancer detectionCA Cancer J Clin2001511387511577479
- MoranLJHutchisonSKNormanRJTeedeHJLifestyle changes in women with polycystic ovary syndromeCochrane Database Syst Rev20112CD007506
- MoranLJPasqualiRTeedeHJHoegerKMNormanRJTreatment of obesity in polycystic ovary syndrome: a position statement of the Androgen Excess and Polycystic Ovary Syndrome SocietyFertil Steril20099261966198219062007
- KnowlerWCBarrett-ConnorEFowlerSEDiabetes Prevention Program Research GroupReduction in the incidence of type 2 diabetes with lifestyle intervention or metforminN Engl J Med2002346639340311832527
- OrioFMuscogiuriGPalombaSCould the Mediterranean diet be effective in women with polycystic ovary syndrome? A proof of conceptEur J Clin Nutr Epub201541
- DomecqJPPrutskyGMullanRJLifestyle modification programs in polycystic ovary syndrome: Systematic review and meta-analysisJ Clin Endocrinol Metab201398124655466324092832
- HarrisonCLLombardCBMoranLJTeedeHJExercise therapy in polycystic ovary syndrome: a systematic reviewHum Reprod Update201117217118320833639
- Escobar-MorrealeHFBotella-CarreteroJIAlvarez-BlascoFSanchoJSan MillánJLThe polycystic ovary syndrome associated with morbid obesity may resolve after weight loss induced by bariatric surgeryJ Clin Endocrinol Metabol2005901263646369
- TeedeHJMissoMLDeeksAAAssessment and management of polycystic ovary syndrome: summary of an evidence-based guidelineMed J Aust20111956S65S11221929505
- VelazquezEMMendozaSHamerTSosaFGlueckCJMetformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancyMetabolism19944356476548177055
- TsilchorozidouTOvertonCConwayGSThe pathophysiology of polycystic ovary syndromeClin Endocrinol (Oxf)200460111714678281
- Nieuwenhuis-RuifrokAEKuchenbeckerWKHoekAMiddletonPNormanRJInsulin sensitizing drugs for weight loss in women of reproductive age who are overweight or obese: systematic review and meta-analysisHum Reprod Update2009151576818927072
- TangTLordJMNormanRJYasminEBalenAHInsulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiroinositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertilityCochrane Database Syst Rev20125CD00305322592687
- CostelloMShresthaBEdenJSjoblomPJohnsonNInsulin-sensitising drugs versus the combined oral contraceptive pill for hirsutism, acne and risk of diabetes, cardiovascular disease, and endometrial cancer in polycystic ovary syndromeCochrane Database Syst Rev20071CD00555217253562
- LiXJYuYXLiuCQMetformin vs thiazolidinediones for treatment of clinical, hormonal and metabolic characteristics of polycystic ovary syndrome: a meta-analysisClin Endocrinol (Oxf)201174333233921050251
- TangTLJNormanRJYasminEBalenAHInsulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertilityCochrane Database Syst Rev20101CD00305320091537
- NissenSEWolskiKRosiglitazone revisited: an updated meta-analysis of risk for myocardial infarction and cardiovascular mortalityArch Int Med2010170141191120120656674
- GambineriASempleRKForlaniGMonogenic polycystic ovary syndrome due to a mutation in the lamin A/C gene is sensitive to thiazolidinediones but not to metforminEur J Endocrinol2008159334735318728124
- TalbottEClericiABergaSLAdverse lipid and coronary heart disease risk profiles in young women with polycystic ovary syndrome: results of a case-control studyJ Clin Epidemiol19985154154229619969